000120630 001__ 120630
000120630 005__ 20240228145457.0
000120630 0247_ $$2doi$$a10.1080/0284186X.2016.1275776
000120630 0247_ $$2pmid$$apmid:28084890
000120630 0247_ $$2ISSN$$a1100-1704
000120630 0247_ $$2ISSN$$a1651-226X
000120630 0247_ $$2ISSN$$a1651-2499
000120630 0247_ $$2altmetric$$aaltmetric:15938146
000120630 037__ $$aDKFZ-2017-01058
000120630 041__ $$aeng
000120630 082__ $$a610
000120630 1001_ $$0P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aSchmidt, Martina$$b0$$eFirst author
000120630 245__ $$aSelf-reported physical activity behavior of breast cancer survivors during and after adjuvant therapy: 12 months follow-up of two randomized exercise intervention trials.
000120630 260__ $$aAbingdon$$bTaylor & Francis Group$$c2017
000120630 3367_ $$2DRIVER$$aarticle
000120630 3367_ $$2DataCite$$aOutput Types/Journal article
000120630 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1662983055_4970
000120630 3367_ $$2BibTeX$$aARTICLE
000120630 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000120630 3367_ $$00$$2EndNote$$aJournal Article
000120630 520__ $$aExercise during and after breast cancer treatment has shown several health benefits. However, little is known about the courses, patterns, and determinants of physical activity of breast cancer patients, and the role of exercise interventions on their physical activity behavior in the long run.Self-reported physical activity was assessed in 227 breast cancer survivors before, during, and three, six, and 12 months post-intervention within two randomized resistance exercise trials performed during adjuvant chemo- or radiotherapy, respectively, with similar designs. Multiple ordinal logistic regression analyses were performed to identify determinants of physical activity at these time points.While the intervention group exercised a median 1.8 h/week during adjuvant therapy (interquartile range 1.4-2.5), 68% of controls did not engage in any exercise. At 12-months follow-up 32% of patients did not engage in any exercise irrespective of the intervention. Of the patients who cycled for transportation pre-diagnosis about half stopped cycling in the long term in both groups. In contrast, walking was maintained over time. Major determinants of low levels of exercise at 12-months follow-up were low pre-diagnosis levels of exercise, lower education, being postmenopausal, and having breast problems or depressive symptoms. Further, the intervention appeared to influence the type of sports performed, with strength exercise being the most common type of exercise at follow-up in the exercise group, more frequently compared to the control group.The exercise intervention effectively countervailed the decrease in physical activity during cancer therapy and boosted strength exercise in the months following the intervention, but in the longer term many survivors were insufficiently active. Breast cancer survivors may need continued motivation and practical support tailored to their individual characteristics and physical activity history to incorporate exercise in everyday routine in the long term.
000120630 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000120630 588__ $$aDataset connected to CrossRef, PubMed,
000120630 7001_ $$0P:(DE-He78)60b584aeef81e4c57fd111fa63779b73$$aWiskemann, Joachim$$b1$$udkfz
000120630 7001_ $$aUlrich, Cornelia M$$b2
000120630 7001_ $$0P:(DE-He78)2dc788b30e99b99a3f9b45ca60f3939d$$aSchneeweiss, Andreas$$b3$$udkfz
000120630 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b4$$eLast author
000120630 773__ $$0PERI:(DE-600)1492623-4$$a10.1080/0284186X.2016.1275776$$gVol. 56, no. 4, p. 618 - 627$$n4$$p618 - 627$$tActa oncologica$$v56$$x0284-186X$$y2017
000120630 909CO $$ooai:inrepo02.dkfz.de:120630$$pVDB
000120630 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000120630 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)60b584aeef81e4c57fd111fa63779b73$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000120630 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2dc788b30e99b99a3f9b45ca60f3939d$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000120630 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000120630 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000120630 9141_ $$y2017
000120630 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000120630 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000120630 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000120630 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000120630 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000120630 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-01-30$$wger
000120630 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bACTA ONCOL : 2019$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-30
000120630 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-01-30
000120630 9201_ $$0I:(DE-He78)G210-20160331$$kG210$$lBewegung, Präventionsforschung und Krebs$$x0
000120630 9201_ $$0I:(DE-He78)V964-20160331$$kV964$$lNCT-KliHD$$x1
000120630 980__ $$ajournal
000120630 980__ $$aVDB
000120630 980__ $$aI:(DE-He78)G210-20160331
000120630 980__ $$aI:(DE-He78)V964-20160331
000120630 980__ $$aUNRESTRICTED